维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Snapinn SM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency:results from the platelet receptor inhibition in ischemic syndrome management in patients limited by unstable signs and symptoms(PRISM-PLUS)trial显示文摘	Januzzi JL Jr Snapinn SM DiBattiste PM	2002	Circulation2002，105，20：	1
2	Tirofiban therapy for patient with acute coronary syndrome and prior coronary artery bypass grafting in the PRISM-PLUS trial显示文摘	Servoss SJ Wan Y Snapinn SM	2004	Am J Cardiol2004，93，7：	1
3	Tirofiban therapy for patient with acute coronary syndrome and prior coro-nary artery bypass grafting in the PRISM-PLUS trial显示文摘	WanY Snapinn SM	2004	Am J Cardiol2004，93，7：	1
4	Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency:results from the Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS)trial显示文摘	Januzzi JL Snapinn SM Di Battiste PM	2002	Circulation2002，105，20：	1
5	Tirofiban therapy for patient with acute eonronary syndrome and prior Coronaryartery by pass grafting in the PRISM-PLUS trial 显示文摘	Servoss SJ Wan Y Snapinn SM	2004	Am J Cardiol2004，93，7：	1
6	An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes显示文摘	Antman EM Snapinn SM	2002	Eur Heart J2002，23，3：	1
7	Benefits and safety of tirofiban among acute coronary syndrome pa-tients with mild to moderate renal insufficiency:results from the Platelet Receptor Inhibition in Ischemic Syn-drome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) trial显示文摘	Snapinn SM DiBattiste PM	2002	Circulation2002，105，20：	1
8	Tirofiban therapy for patient with acute conronary syndrome and prior coronary artery bypass grafting in the PRISM-PLUS trial 显示文摘	Servoss SJ WanY Snapinn SM	2004	Am J Cardiol2004，93，7：	1
9	Tirofiban therapy for patient with acute coronary syndrome and prior coronary artery bypass grafting in the PRISM-PLUS trial显示文摘	Servoss SJ WanY Snapinn SM	2004	Am J Cardiol2004，93，：	1
10	Benefits and safety of tirofiban among acute coronary syndrome patients with mild to moderate renal insufficiency:results from the platelet recetptor inhibition in ischemic syndrome management in patients limited by unstable signs and symptoms ( PRISM-PLUS ) tral显示文摘	Januzzi JL Snapinn SM DiBattiste PM	2002	Circulation2002，105，20：	1
11	Tirofiban therapy for patients with acute coronary syndromes and prior coronary artery bypass grafting in the PRISM-PLUS trial显示文摘	Servoss SJ Wan Y Snapinn SM	2004	Am J Cardiol2004，93，7：	1
12	Benefits andsafety of tirofiban among acute coronary syndrome patientswith mild to moderate renal insufficiency: results from thePlatelet Receptor Inhibition in Ischemic SyndromeManagement in Patients Limited by Unstable Signs andSymptoms (PRISM-PLUS) trial 显示文摘	Januzzi JL Jr Snapinn SM DiBattiste PM	2002	Circulation2002，105，20：	1
13	Alternatives for discounting in the analysis of noninferiority trials显示文摘	Snapinn SM	2004	Journal of Biopharmaceutical Statistics2004，14，：	1
14	Sexbased short-and long-term survival in patients following complicated myocardial infarction显示文摘	Bonarjee W Rosengren A Snapinn SM	2006	Eur Heart J2006，27，18：	1
15	Statins for secondary prevention of cardiovascu-lar disease:the right dose显示文摘	Spector R Snapinn SM	2011	Pharmacology2011，87，12：	1
16	Sex-based short-and long-term survival in patients following complicated myocardial infarction 显示文摘	Bonarjee VV Rosengren A Snapinn SM	2006	Eur Heart J2006，27，18：	1
17	Statins for secondary prevention of cardiovascular disease:the right dose显示文摘	Spector R Snapinn SM	2011	Pharmacology2011，87，：	1
18	Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy显示文摘	Brenner BM Cooper ME de Zeeuw D Keane WF Mitch WE Parving HH Remuzzi G Snapinn SM Zhang Z Shahinfar S RENAAL Study Investigators	2001	N Engl J Med2001，345，12：	1
19	An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes:pplication of the TIMI risk score for UMNSTE-MI in PRISM-Plus显示文摘	Morrow DA Antmen EM Snapinn SM	2002	Eur Heart J2002，23，：	1
20	An integrated clinical approach to predicting the benefit of tirofiban in non ST elevation acute coronary syndromes 显示文摘	Morrow DA Autman EM Snapinn SM	2002	Eur Heart J2002，23，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示